{"id":"https://openalex.org/W4362543548","doi":"https://doi.org/10.1158/1538-7445.am2023-3455","title":"Abstract 3455: Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance","display_name":"Abstract 3455: Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362543548","doi":"https://doi.org/10.1158/1538-7445.am2023-3455"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-3455","doi":"https://doi.org/10.1158/1538-7445.am2023-3455","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-3455","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032230417","display_name":"Vakul Mohanty","orcid":"https://orcid.org/0000-0002-5536-6750","observed_orcids":["https://orcid.org/0000-0002-5536-6750"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vakul Mohanty","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058898565","display_name":"Natalia Baran","orcid":"https://orcid.org/0000-0003-0618-4798","observed_orcids":["https://orcid.org/0000-0003-0618-4798"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalia Baran","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102202556","display_name":"Yuefan Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuefan Huang","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101518934","display_name":"Shan He","orcid":"https://orcid.org/0000-0003-2981-7498","observed_orcids":["https://orcid.org/0000-0003-2981-7498"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan He","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029244923","display_name":"Ramiz Iqbal","orcid":"https://orcid.org/0000-0001-6718-1369","observed_orcids":["https://orcid.org/0000-0001-6718-1369"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramiz Iqbal","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Tyner","raw_affiliation_strings":["2OHSU Knight Cancer Insitute, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OHSU Knight Cancer Insitute, Portland, OR;","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon Mills","raw_affiliation_strings":["3OHSU Knight Cancer Institute, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3OHSU Knight Cancer Institute, Portland, OR;","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112374856","display_name":"Marina Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["4Albert Einstein College of Medicine, Bronx, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Albert Einstein College of Medicine, Bronx, NY","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100420347","display_name":"Ken Chen","orcid":"https://orcid.org/0000-0003-4013-5279","observed_orcids":["https://orcid.org/0000-0003-4013-5279"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ken Chen","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"3455","last_page":"3455"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.9869999885559082},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.6859999895095825},{"id":"https://openalex.org/keywords/transcriptional-heterogeneity","display_name":"transcriptional heterogeneity","score":0.7889999747276306},{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.8220000267028809},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.718999981880188},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dnmt3a-mutation","display_name":"DNMT3A mutation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.7519999742507935},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8870000243186951},{"id":"https://openalex.org/keywords/srsf2-mutation","display_name":"SRSF2 mutation","score":0.9480000138282776},{"id":"https://openalex.org/keywords/interferon-signaling","display_name":"interferon signaling","score":0.7049999833106995},{"id":"https://openalex.org/keywords/metabolic-fitness","display_name":"metabolic fitness","score":0.5619999766349792},{"id":"https://openalex.org/keywords/pi3k-mtor-signaling","display_name":"PI3K/mTOR signaling","score":0.8420000076293945},{"id":"https://openalex.org/keywords/oxidative-phosphorylation","display_name":"oxidative phosphorylation","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7157686948776245},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6189934611320496},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.6026210188865662},{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.5681155920028687},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5563162565231323},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5531821250915527},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5345090627670288},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.5266335606575012},{"id":"https://openalex.org/C2779733811","wikidata":"https://www.wikidata.org/wiki/Q5531562","display_name":"Gene signature","level":4,"score":0.5258175134658813},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3550261855125427},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.32119590044021606},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.286238431930542},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2595983147621155},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.21400165557861328},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19530391693115234},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.16754227876663208},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11761793494224548},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-3455","doi":"https://doi.org/10.1158/1538-7445.am2023-3455","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-3455","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405039763","https://openalex.org/W4391517959","https://openalex.org/W4417010191","https://openalex.org/W6991704953","https://openalex.org/W4387846026","https://openalex.org/W4414780365","https://openalex.org/W4285744587","https://openalex.org/W3001120382","https://openalex.org/W4393076004","https://openalex.org/W7108625628"],"abstract_inverted_index":{"Abstract":[0],"Venetoclax":[1],"(VEN),":[2],"an":[3,10,178],"inhibitor":[4],"of":[5,21,39,60,96,106,144,203,242,247,269,296,350,363,398,436],"anti-apoptotic":[6],"protein":[7],"BCL2":[8],"is":[9,28,191],"important":[11],"therapeutic":[12,294,393],"intervention":[13],"in":[14,42,78,128,136,189,328,386],"acute":[15],"myeloid":[16],"leukemia":[17],"(AML).":[18],"However,":[19],"development":[20,397],"resistance":[22,43,61,73,127,323,432],"to":[23,36,85,176,219,231,257],"VEN":[24,72,97,126,258,319],"and":[25,80,89,113,131,146,149,155,162,185,195,201,205,212,245,266,271,283,293,311,322,340,382,390,396,427,449],"its":[26],"combinations":[27],"common,":[29],"which":[30,181,208],"poses":[31],"a":[32,71,284,308],"significant":[33],"clinical":[34],"challenge":[35],"the":[37,54,87,102,232,279,291,329,351,366,374,437],"management":[38],"AML.":[40],"Heterogeneity":[41],"can":[44,391],"exist":[45],"not":[46],"only":[47],"across":[48],"different":[49],"tumors":[50],"but":[51,261],"also":[52,172,215,227],"within":[53],"same":[55],"tumor.":[56],"While":[57,354],"some":[58],"mechanisms":[59],"have":[62],"been":[63],"revealed,":[64],"others":[65],"remain":[66],"elusive.":[67],"Here,":[68],"we":[69,120,334],"derive":[70],"signature":[74,88],"from":[75,117,307],"AML":[76,99,225,281],"cell-lines":[77,226],"CCLE,":[79],"utilize":[81],"non-negative":[82],"matrix":[83],"factorization":[84],"decompose":[86],"systematically":[90,380],"define":[91],"four":[92],"transcriptionally":[93,255],"distinct":[94,122],"clusters":[95,130,277,298],"resistant":[98,345,388],"patient":[100,309,330],"using":[101,278],"BeatAML":[103,286],"cohort,":[104],"consisting":[105],"186":[107],"patients.":[108],"By":[109],"integrating":[110],"gene":[111],"expression":[112,123],"drug":[114],"response":[115],"profiles":[116],"these":[118,129,276,297],"patients,":[119,260],"elucidate":[121],"programs":[124],"underlying":[125],"their":[132],"associated":[133],"vulnerabilities.":[134],"Samples":[135],"Cluster":[137,187,223,236,251,337,341,355,369],"1":[138,338,356,447],"are":[139,254],"characterized":[140,192,360,383],"by":[141,193,299,361],"high":[142,156,198,240],"frequency":[143],"DNMT3A":[145,270],"RAS":[147],"(KRAS":[148],"NRAS)":[150],"mutations,":[151,197],"strong":[152],"monocytic":[153],"phenotype":[154],"PI3K-mTOR":[157],"signaling,":[158,207],"oxidative":[159],"phosphorylation":[160],"(OXPHOS)":[161],"fatty":[163],"acid":[164],"metabolism,":[165],"indicating":[166],"improved":[167],"metabolic":[168,364],"fitness.":[169],"These":[170],"samples":[171,238,253],"show":[173,216,228,262],"remarkable":[174,229],"sensitivity":[175,218,230],"panobinostat,":[177],"HDAC":[179],"inhibitor,":[180,234],"suppresses":[182],"mTORC1":[183],"signaling":[184,265],"OXPHOS.":[186],"3,":[188],"contrast,":[190],"TP53":[194],"SRSF2":[196],"CTL":[199],"infiltration":[200],"activation":[202,362],"JAK-STAT":[204],"MAPK":[206],"regulate":[209],"pro-survival":[210],"pathways":[211],"proliferation.":[213],"They":[214],"selective":[217],"JAK":[220,233],"family":[221],"inhibitors.":[222],"3-like":[224],"ruxolitinib.":[235],"2":[237,342,370],"exhibit":[239],"rates":[241,268],"NRAS":[243],"mutations":[244],"suppression":[246],"HOX":[248],"genes.":[249],"Finally,":[250],"4":[252],"similar":[256],"sensitive":[259,320],"higher":[263,267],"interferon":[264],"IDH1":[272],"mutations.":[273],"We":[274],"validated":[275],"TCGA":[280],"(n=173)":[282],"second":[285],"cohort":[287],"(n=182).We":[288],"further":[289],"confirmed":[290],"existence":[292],"value":[295],"projecting":[300],"them":[301],"onto":[302],"single-cell":[303],"RNA-seq":[304],"data":[305],"obtained":[306],"before":[310],"after":[312,376],"VEN+azacitidine":[313],"treatment.":[314],"In":[315],"pre-treatment":[316],"cells,":[317],"both":[318],"(41%)":[321],"(59%)":[324],"signatures":[325],"were":[326,359],"present":[327],"tumor,":[331],"however,":[332],"post-treatment":[333],"observed":[335],"that":[336],"(5%)":[339],"(93%)":[343],"like":[344,357,371],"cells":[346,358,372],"accounted":[347],"for":[348,440],"most":[349],"tumor":[352,375],"cells.":[353],"pathways,":[365],"more":[367],"proliferative":[368],"dominated":[373],"relapse.":[377],"Our":[378],"study":[379],"identified":[381],"mechanistic":[384],"heterogeneity":[385,429],"venetoclax":[387,431],"AMLs":[389],"aid":[392],"decision":[394],"making":[395],"effective":[399],"combination":[400],"therapies":[401],"with":[402],"venetoclax.":[403],"Citation":[404],"Format:":[405],"Vakul":[406],"Mohanty,":[407],"Natalia":[408],"Baran,":[409],"Yuefan":[410],"Huang,":[411],"Shan":[412],"He,":[413],"Ramiz":[414],"Iqbal,":[415],"CTD2":[416],"consortium,":[417],"Jeffrey":[418],"Tyner,":[419],"Gordon":[420],"Mills,":[421],"Marina":[422],"Konopleva,":[423],"Ken":[424],"Chen.":[425],"Transcriptional":[426],"phenotypic":[428],"underpinning":[430],"[abstract].":[433],"In:":[434],"Proceedings":[435],"American":[438],"Association":[439],"Cancer":[441,460],"Research":[442],"Annual":[443],"Meeting":[444],"2023;":[445],"Part":[446],"(Regular":[448],"Invited":[450],"Abstracts);":[451],"2023":[452],"Apr":[453],"14-19;":[454],"Orlando,":[455],"FL.":[456],"Philadelphia":[457],"(PA):":[458],"AACR;":[459],"Res":[461],"2023;83(7_Suppl):Abstract":[462],"nr":[463],"3455.":[464]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}